The analyst has maintained a Positive rating on Endava, but the lowered price target indicates some caution due to industry uncertainty. The decline in revenue per workday growth and potential risks, such as losing a top 10 customer or a market slowdown, may have a negative impact on the stock. However, the company's expected benefits from technological change and the DEK acquisition could offset these risks, resulting in a neutral short-term impact.